344 related articles for article (PubMed ID: 31911890)
21. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
[TBL] [Abstract][Full Text] [Related]
22. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
23. β-cyclodextrin based dual-responsive multifunctional nanotheranostics for cancer cell targeting and dual drug delivery.
Das M; Solanki A; Joshi A; Devkar R; Seshadri S; Thakore S
Carbohydr Polym; 2019 Feb; 206():694-705. PubMed ID: 30553374
[TBL] [Abstract][Full Text] [Related]
24. Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene.
Patil BR; Kang SY; Jung DH; Avaji PG; Jun YJ; Lee HJ; Sohn YS
Int J Nanomedicine; 2020; 15():981-990. PubMed ID: 32103951
[TBL] [Abstract][Full Text] [Related]
25. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor (EGF) fragment-guided anticancer theranostic particles for pH-responsive release of doxorubicin.
Kang MK; Mao W; Lee JB; Yoo HS
Int J Pharm; 2017 Mar; 519(1-2):104-112. PubMed ID: 28087384
[TBL] [Abstract][Full Text] [Related]
27. Redox-responsive nanoparticles from disulfide bond-linked poly-(N-ε-carbobenzyloxy-l-lysine)-grafted hyaluronan copolymers as theranostic nanoparticles for tumor-targeted MRI and chemotherapy.
Yang H; Miao Y; Chen L; Li Z; Yang R; Xu X; Liu Z; Zhang LM; Jiang X
Int J Biol Macromol; 2020 Apr; 148():483-492. PubMed ID: 31926232
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Fathi M; Barar J; Erfan-Niya H; Omidi Y
Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
Mosayebi J; Kiyasatfar M; Laurent S
Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
[TBL] [Abstract][Full Text] [Related]
31. Iron oxide-gold core-shell nano-theranostic for magnetically targeted photothermal therapy under magnetic resonance imaging guidance.
Abed Z; Beik J; Laurent S; Eslahi N; Khani T; Davani ES; Ghaznavi H; Shakeri-Zadeh A
J Cancer Res Clin Oncol; 2019 May; 145(5):1213-1219. PubMed ID: 30847551
[TBL] [Abstract][Full Text] [Related]
32. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
[TBL] [Abstract][Full Text] [Related]
33. In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery.
Rahimi M; Wadajkar A; Subramanian K; Yousef M; Cui W; Hsieh JT; Nguyen KT
Nanomedicine; 2010 Oct; 6(5):672-80. PubMed ID: 20172050
[TBL] [Abstract][Full Text] [Related]
34. Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
Satpathy M; Wang L; Zielinski RJ; Qian W; Wang YA; Mohs AM; Kairdolf BA; Ji X; Capala J; Lipowska M; Nie S; Mao H; Yang L
Theranostics; 2019; 9(3):778-795. PubMed ID: 30809308
[TBL] [Abstract][Full Text] [Related]
35. Magnetofluorescent nanohybrid comprising polyglycerol grafted carbon dots and iron oxides: Colloidal synthesis and applications in cellular imaging and magnetically enhanced drug delivery.
Wen Y; Xu M; Liu X; Jin X; Kang J; Xu D; Sang H; Gao P; Chen X; Zhao L
Colloids Surf B Biointerfaces; 2019 Jan; 173():842-850. PubMed ID: 30551300
[TBL] [Abstract][Full Text] [Related]
36. High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics.
Sun Y; Yan C; Xie J; Yan D; Hu K; Huang S; Liu J; Zhang Y; Gu N; Xiong F
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29536-29548. PubMed ID: 31333014
[TBL] [Abstract][Full Text] [Related]
37. Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.
Abedi M; Abolmaali SS; Abedanzadeh M; Farjadian F; Mohammadi Samani S; Tamaddon AM
Int J Nanomedicine; 2020; 15():2617-2631. PubMed ID: 32368044
[TBL] [Abstract][Full Text] [Related]
38. pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers.
Min KH; Min HS; Lee HJ; Park DJ; Yhee JY; Kim K; Kwon IC; Jeong SY; Silvestre OF; Chen X; Hwang YS; Kim EC; Lee SC
ACS Nano; 2015 Jan; 9(1):134-45. PubMed ID: 25559896
[TBL] [Abstract][Full Text] [Related]
39. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
Abbasi AZ; Prasad P; Cai P; He C; Foltz WD; Amini MA; Gordijo CR; Rauth AM; Wu XY
J Control Release; 2015 Jul; 209():186-96. PubMed ID: 25908171
[TBL] [Abstract][Full Text] [Related]
40. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
